Patient Characteristics at Enrollment
| . | Institutional . | Compassionate . |
|---|---|---|
| Number | 14 | 28 |
| Median age (range) | 57 (46-73) | 56 (46-68) |
| Men/women | 10/4 | 17/11 |
| M-component: lambda/kappa/not specified | 13/1/0 | 11/4/13 |
| ECOG performance status: 1/2/3/not specified | 7/5/2/0 | 2/19/4/3 |
| Prior chemotherapy: yes/no/not specified | 9/5/0 | 22/2/4 |
| Dominant organ involvement: | ||
| Kidney/heart | 4/1 | 9/4 |
| Liver/peripheral nervous system | 1/2 | 3/4 |
| Soft tissues/other | 5/1 | 2/6 |
| . | Institutional . | Compassionate . |
|---|---|---|
| Number | 14 | 28 |
| Median age (range) | 57 (46-73) | 56 (46-68) |
| Men/women | 10/4 | 17/11 |
| M-component: lambda/kappa/not specified | 13/1/0 | 11/4/13 |
| ECOG performance status: 1/2/3/not specified | 7/5/2/0 | 2/19/4/3 |
| Prior chemotherapy: yes/no/not specified | 9/5/0 | 22/2/4 |
| Dominant organ involvement: | ||
| Kidney/heart | 4/1 | 9/4 |
| Liver/peripheral nervous system | 1/2 | 3/4 |
| Soft tissues/other | 5/1 | 2/6 |